Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir

Nature Structural and Molecular Biology

Volumn 11, Issue 5, 2004, Pages 469-474

  Tuske, Steve ^a,b   Sarafianos, Stefan G ^a,b   Clark Jr , Arthur D ^a,b   Ding, Jianping ^a,b,c   Naeger, Lisa K ^d   White, Kirsten L ^d   Miller, Michael D ^d   Gibbs, Craig S ^d   Boyer, Paul L ^e   Clark, Patrick ^e   Wang, Gang ^b   Gaffney, Barbara L ^b   Jones, Roger A ^b   Jerina, Donald M ^f   Hughes, Stephen H ^e   Arnold, Eddy ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^d GILEAD SCIENCES   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; PRIMER DNA; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; ZIDOVUDINE;

ANTIBIOTIC RESISTANCE; ARTICLE; CONFORMATION; CONTROLLED STUDY; CROSS LINKING; CRYSTAL STRUCTURE; DNA DRUG COMPLEX; DNA PROTEIN COMPLEX; DNA TEMPLATE; DRUG DNA BINDING; DRUG STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; VIRUS ENVELOPE;

ADENINE; BASE SEQUENCE; DNA PRIMERS; DNA, VIRAL; HIV-1 REVERSE TRANSCRIPTASE; MODELS, MOLECULAR; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; REVERSE TRANSCRIPTASE INHIBITORS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 2342453265     PISSN: 15459993     EISSN: None     Source Type: Journal    
DOI: 10.1038/nsmb760     Document Type: Article

References (34)

1. Huang, H., Chopra, R., Verdine, G.L. & Harrison, S.C. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 282, 1669-1675 (1998).
2. Sarafianos, S.G. et al. Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with β-branched amino acids. Proc. Natl. Acad. Sci. USA 96, 10027-10032 (1999).
3. Gao, H.Q., Boyer, P.L., Sarafianos, S.G., Arnold, E. & Hughes, S.H. The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase. J. Mol. Biol. 300, 403-418 (2000).
4. Boyer, P.L. et al. YADD mutants of human immunodeficiency virus type 1 and Moloney murine leukemia virus reverse transcriptase are resistant to lamivudine triphosphate (3TCTP) in vitro. J. Virol. 75, 6321-6328 (2001).
5. Arion, D., Kaushik, N., McCormick, S., Borkow, G. & Parniak, M.A. Phenotypic mechanism of HIV-1 resistance to 3_-azido-3_-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase. Biochemistry 37, 15908-15917 (1998).
6. Meyer, P.R., Matsuura, S.E., Mian, A.M., So, A.G. & Scott, W.A. A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase. Mol. Cell 4, 35-43 (1999).
7. Boyer, P.L., Sarafianos, S.G., Arnold, E. & Hughes, S.H. Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase. J. Virol. 75, 4832-4842 (2001).
8. Boyer, P.L., Sarafianos, S.G., Arnold, E. & Hughes, S.H. The M184V mutation reduces the selective excision of zidovudine 5_-monophosphate (AZTMP) by the reverse transcriptase of human immunodeficiency virus type 1. J. Virol. 76, 3248-3256 (2002).
9. Srinivas, R. & Fridland, A. Antiviral activities of 9-R-2 phosphonomethoxypropyl adenine (PMPA) and bis(isopropyloxymethylcarbonyl)PMPA against various drug-resistant human immunodeficiency virus strains. Antimicrob. Agents Chemother. 42, 1484-1487 (1998).
10. Wainberg, M.A. et al. In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA. Antivir. Ther. 4, 87-94 (1999).
11. Margot N.A., et al. Genotypic and phenotypic analyses of HIV-1 in antiretroviral-experienced patients treated with tenofovir DF. AIDS 16, 1227-1235 (2002).
12. Jacobo-Molina, A. et al. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc. Natl. Acad. Sci. USA 90, 6320-6324 (1993).
13. Ding, J. et al. Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with double-stranded DNA and an antibody Fab fragment at 2.8 Å resolution. J. Mol. Biol. 284, 1095-1111 (1998).
14. Sarafianos, S.G. et al. Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. EMBO J. 20, 1449-1461 (2001).
15. Sarafianos, S.G. et al. Structures of HIV-1 reverse transcriptase with pre-and post-translocation AZTMP-terminated DNA. EMBO J. 21, 6614-6624 (2002).
16. Doublie, S., Tabor, S., Long, A.M., Richardson, C.C. & Ellenberger, T. Crystal structure of a bacteriophage T7 DNA replication complex at 2.2 A resolution. Nature 391, 251-258 (1998).
17. Li, Y., Korolev, S. & Waksman, G. Crystal structures of open and closed forms of binary and ternary complexes of the large fragment of Thermus aquaticus DNA polymerase: structural basis for nucleotide incorporation. EMBO J. 17, 7514-7525 (1998).
18. Dahlberg, M.E. & Benkovic, S.J. Kinetic mechanism of DNA polymerase I (Klenow fragment): identification of a second conformational change. Biochemistry 30, 4835-4843 (1991).
19. Hsieh, J., Zinnen, S. & Modrich, P. Kinetic mechanism of the DNA-dependent DNA polymerase activity of human immunodeficiency virus reverse transcriptase. J. Biol. Chem. 268, 24607-24613 (1993).
20. Kati, W.M., Johnson, K.A., Jerva, L.F. & Anderson, K.S. Mechanism and fidelity of HIV reverse transcriptase. J. Biol. Chem. 267, 25988-25997 (1992).
21. Suo, Z. & Johnson, K.A. Selective inhibition of HIV-1 reverse transcriptase by an antiviral inhibitor (R)-9-(2-phosphonylmethoxypropyl)adenine. J. Biol. Chem. 273, 27250-27258 (1998).
22. Prabu-Jeyabalan, M., Nalivaika, E. & Schiffer, C.A. Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes. Structure 10, 369-381 (2002).
23. White, K.L. et al. Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M 184V and their effects on enzyme function and viral replication capacity. Antimicrob. Agents Chemother. 46, 3437-3446 (2002).
24. Selmi, B., Boretto, J., Sarfati, S.R., Guerreiro, C. & Canard, B. Mechanism-based suppression of dideoxynucleotide resistance by K65R human immunodeficiency virus reverse transcriptase using an α-boranophosphate nucleoside analogue. J. Biol. Chem. 276, 48466-48472 (2001).
25. Arion, D., Borkow, G., Gu, Z., Wainberg, M.A. & Parniak, M.A. The K65R mutation confers increased DNA polymerase processivity to HIV-1 reverse transcriptase. J. Biol. Chem. 271, 19860-19864 (1996).
26. Miller, M.D. et al. Characterization of resistance mutation patterns emerging over two years during first line antiretroviral treatment with tenofovir DF or stavudine in combination with lamivudine and efavirenz. Antivir. Ther. 8, S1-S185 (2003).
27. Boyer, P.L., Sarafianos, S., Arnold, E. & Hughes, S.H. Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus typel reverse transcriptase involves ATP-mediated excision. J. Virol. 76, 9143-9151 (2002).
28. Harrigan, P.R., Miller, M.D., McKenna, P., Brumme, Z.L. & Larder, B.A. Phenotypic susceptibilities to tenofovir in a large panel of clinically derived human immunodeficiency virus type 1 isolates. Antimicrob. Agents Chemother. 46, 1067-1072 (2002).
29. Mas, A. et al. Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance. EMBO J. 19, 5752-5761 (2000).
30. Sarafianos, S.G. et al. Trapping HIV-1 reverse transcriptase before and after translocation on DNA. J. Biol. Chem. 278, 16280-16288 (2003).
31. DeCorte, B.L. et al. Improved strategies for postoligomerization synthesis of oligodeoxynucleotides bearing structurally defined adducts at the N2 position of deoxyguanosine. Chem. Res. Toxicol. 9, 630-637 (1996).
32. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997).
33. Brunger, A.T. et al. Crystallography & NMR system (CNS): a new software system for macromolecular structure determination. Acta Crystallogr. D 54, 905-921 (1998).
34. Jones, T.A., Zou, J.Y., Cowan, S.W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110-119 (1991).